These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 19339281)

  • 41. Risedronate increases osteoblastic differentiation and function through connexin43.
    Jeong HM; Jin YH; Choi YH; Chung JO; Cho DH; Chung MY; Civitelli R; Chung DJ; Lee KY
    Biochem Biophys Res Commun; 2013 Mar; 432(1):152-6. PubMed ID: 23376077
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Growth hormone attenuates the transcriptional activity of Runx2 by facilitating its physical association with Stat3beta.
    Ziros PG; Georgakopoulos T; Habeos I; Basdra EK; Papavassiliou AG
    J Bone Miner Res; 2004 Nov; 19(11):1892-904. PubMed ID: 15476590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epidermal growth factor induces fibroblast contractility and motility via a protein kinase C delta-dependent pathway.
    Iwabu A; Smith K; Allen FD; Lauffenburger DA; Wells A
    J Biol Chem; 2004 Apr; 279(15):14551-60. PubMed ID: 14747473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter.
    Niger C; Lima F; Yoo DJ; Gupta RR; Buo AM; Hebert C; Stains JP
    Bone; 2011 Oct; 49(4):683-92. PubMed ID: 21820092
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intermittent Administration of Parathyroid Hormone 1-34 Enhances Osteogenesis of Human Mesenchymal Stem Cells by Regulating Protein Kinase Cδ.
    Kuo SW; Rimando MG; Liu YS; Lee OK
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29064396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mitogen activated protein kinase-dependent inhibition of osteocalcin gene expression by transforming growth factor-beta1.
    Kwok S; Partridge NC; Srinivasan N; Nair SV; Selvamurugan N
    J Cell Biochem; 2009 Jan; 106(1):161-9. PubMed ID: 19051235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nell-1, a key functional mediator of Runx2, partially rescues calvarial defects in Runx2(+/-) mice.
    Zhang X; Ting K; Bessette CM; Culiat CT; Sung SJ; Lee H; Chen F; Shen J; Wang JJ; Kuroda S; Soo C
    J Bone Miner Res; 2011 Apr; 26(4):777-91. PubMed ID: 20939017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rottlerin inhibits tonicity-dependent expression and action of TonEBP in a PKCdelta-independent fashion.
    Zhao H; Tian W; Cohen DM
    Am J Physiol Renal Physiol; 2002 Apr; 282(4):F710-7. PubMed ID: 11880333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progressive recruitment of Runx2 to genomic targets despite decreasing expression during osteoblast differentiation.
    Pregizer S; Baniwal SK; Yan X; Borok Z; Frenkel B
    J Cell Biochem; 2008 Nov; 105(4):965-70. PubMed ID: 18821584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fibroblast growth factor activation of the rat PRL promoter is mediated by PKCdelta.
    Jackson TA; Schweppe RE; Koterwas DM; Bradford AP
    Mol Endocrinol; 2001 Sep; 15(9):1517-28. PubMed ID: 11518800
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of cyclin D3 through Sp1 sites by histone deacetylase inhibitors is mediated with protein kinase C-delta (PKC-delta) signal pathway.
    Kim YH; Lim JH; Lee TJ; Park JW; Kwon TK
    J Cell Biochem; 2007 Jul; 101(4):987-95. PubMed ID: 17407153
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome.
    Guenou H; Kaabeche K; Mée SL; Marie PJ
    Hum Mol Genet; 2005 Jun; 14(11):1429-39. PubMed ID: 15829502
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulation of osteocalcin gene expression by a novel Ku antigen transcription factor complex.
    Willis DM; Loewy AP; Charlton-Kachigian N; Shao JS; Ornitz DM; Towler DA
    J Biol Chem; 2002 Oct; 277(40):37280-91. PubMed ID: 12145306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Connexin43 intercellular communication drives the early differentiation of human bone marrow stromal cells into osteoblasts.
    Talbot J; Brion R; Lamora A; Mullard M; Morice S; Heymann D; Verrecchia F
    J Cell Physiol; 2018 Feb; 233(2):946-957. PubMed ID: 28369869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rottlerin induces apoptosis via death receptor 5 (DR5) upregulation through CHOP-dependent and PKC delta-independent mechanism in human malignant tumor cells.
    Lim JH; Park JW; Choi KS; Park YB; Kwon TK
    Carcinogenesis; 2009 May; 30(5):729-36. PubMed ID: 19037087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein kinase Cδ-mediated phosphorylation of Connexin43 gap junction channels causes movement within gap junctions followed by vesicle internalization and protein degradation.
    Cone AC; Cavin G; Ambrosi C; Hakozaki H; Wu-Zhang AX; Kunkel MT; Newton AC; Sosinsky GE
    J Biol Chem; 2014 Mar; 289(13):8781-98. PubMed ID: 24500718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.
    Sowa H; Kaji H; Hendy GN; Canaff L; Komori T; Sugimoto T; Chihara K
    J Biol Chem; 2004 Sep; 279(39):40267-75. PubMed ID: 15150273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fibroblast growth factor 2 regulates bone sialoprotein gene transcription in human breast cancer cells.
    Li Z; Wang Z; Yang L; Li X; Sasaki Y; Wang S; Araki S; Mezawa M; Takai H; Nakayama Y; Ogata Y
    J Oral Sci; 2010 Mar; 52(1):125-32. PubMed ID: 20339243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EGFR signaling suppresses osteoblast differentiation and inhibits expression of master osteoblastic transcription factors Runx2 and Osterix.
    Zhu J; Shimizu E; Zhang X; Partridge NC; Qin L
    J Cell Biochem; 2011 Jul; 112(7):1749-60. PubMed ID: 21381079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. YY1 represses the transcriptional activity of Runx2 in C2C12 cells.
    Jeong HM; Choi YH; Lee SH; Lee KY
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):103-10. PubMed ID: 24325869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.